Microenvironmental Regulation of Mammary Carcinogenesis

Abstract

During breast cancer development, increased presence of leukocytes in stroma parallels disease progression; however, functional significance of leukocytes in regulating pro- versus anti-tumor immunity in the breast remains poorly understood. Utilizing the MMTV-PyMT model of mammary carcinogenesis, we have demonstrated that cathepsin C-expressing macrophages and IL-4-expressing CD4+ T cells indirectly promote invasion and subsequent metastasis of mammary adenocarcinomas. CD4+ T cells regulate the phenotype and effector function of macrophages that in turn enhance metastasis through activation of EGF receptor signaling in malignant epithelial cells. Together, these data indicate that anti-tumor acquired immune programs can be usurped in pro-tumor microenvironments and instead promote malignancy by engaging cellular components of the innate immune system functionally involved in regulating epithelial cell behavior. Based on this data, we revealed a unique immune signature that predicts overall survival of women with breast cancer. Moreover, we have revealed that transient blockade of Alk5 enhances delivery of high molecular weight compounds into mammary tumors. We will employ this capability and evaluate cell-based delivery systems and targeted-iron oxide imaging compounds to non-invasively evaluate "inflammation" in mammary carcinomas, to not only target leukocytes to minimize their tumor-promoting activities, but also to develop imaging modalities to predict outcome for patients and help guide therapy.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jun 01, 2009
Accession Number
ADA514035

Entities

People

  • Lisa Coussens

Organizations

  • University of California, San Francisco

Tags

DTIC Thesaurus Topics

  • Cell Physiological Processes
  • Cells
  • Chemical Synthesis
  • Chemistry
  • Health Services
  • Lymphocytes
  • Medical Personnel
  • Oncology
  • Peptide Growth Factors
  • Peptides

Readers

  • Oncology (Cancer Research).